LOGIN
Aspirin reduces risk of recurrence in patients with unprovoked venous thromboembolism
August 2013
Aspirin reduces risk of recurrence in patients with unprovoked venous thromboembolism
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Aspirin for preventing the recurrence of venous thromboembolism
N Engl J Med. 2012 May 24;366(21):1959-67. doi: 10.1056/NEJMoa1114238Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Two weeks following the completion of treatment with vitamin K antagonists, 403 patients with a previous unprovoked venous thromboembolism (VTE) were randomised into two groups. Patients either received 100 mg aspirin or a placebo, once per day for 2 years, to measure the recurrence of VTE. Following assessments every 3 months in the first year and every 6 months in the second year, the results de...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.